» Articles » PMID: 33563816

Herpes Simplex Virus 1 Manipulates Host Cell Antiviral and Proviral DNA Damage Responses

Overview
Journal mBio
Specialty Microbiology
Date 2021 Feb 10
PMID 33563816
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Cells activate their DNA damage response (DDR) in response to DNA virus infection, including adenoviruses, papillomaviruses, polyomaviruses, and herpesviruses. In this study, we found that the DDR kinase pathways activated in normal human fibroblasts by herpes simplex virus 1 (HSV-1) input genomic DNA, HSV-1 replicating DNA, and progeny DNA and in uninfected cells treated with etoposide are different. We also found using clustered regularly interspaced palindromic repeat (CRISPR)-Cas9 technology that different host gene products are required for the DDR in uninfected versus infected cells. Individual DDR components can be proviral or antiviral in that ataxia-telangiectasia mutated (ATM) and p53 promote and Mre11 restricts replication of ICP0-null HSV-1, but ICP0 expression eliminates these DDR effects. Thus, in total, these results argue that HSV-1 manipulates the host cell DDR to utilize specific components for its optimal replication while inactivating the antiviral aspects of the DDR. We investigated the relationship between the DNA damage response, a collection of vital cellular pathways that repair potentially lethal damage to the genome, and the DNA virus herpes simplex virus 1. We found that infection by the virus triggers the DNA damage response, and key proteins that mediate this response have opposing effects on the replication and production of progeny viruses. Our work provides novel insights into the relationship between DNA virus infection and the cellular response to the viral genome. We speculate that viral gene products modulate this response, providing potentially novel targets for therapeutic intervention against the virus.

Citing Articles

Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis.

Friedenson B JMIRx Med. 2025; 6:e50712.

PMID: 39885374 PMC: 11796484. DOI: 10.2196/50712.


Identifying Protein Interactions with Viral DNA Genomes during Virus Infection.

Packard J, Kumar N, Weitzman M, Dembowski J Viruses. 2024; 16(6).

PMID: 38932138 PMC: 11209293. DOI: 10.3390/v16060845.


Cell Intrinsic Determinants of Alpha Herpesvirus Latency and Pathogenesis in the Nervous System.

Salazar S, Luong K, Koyuncu O Viruses. 2023; 15(12).

PMID: 38140525 PMC: 10747186. DOI: 10.3390/v15122284.


Nuclear interferon-stimulated gene product maintains heterochromatin on the herpes simplex viral genome to limit lytic infection.

Sodroski C, Knipe D Proc Natl Acad Sci U S A. 2023; 120(45):e2310996120.

PMID: 37883416 PMC: 10636318. DOI: 10.1073/pnas.2310996120.


Herpes simplex virus infected cell protein 8 is required for viral inhibition of the cGAS pathway.

Broekema N, Mertens M, Angelova M, Orzalli M, Oh H, Knipe D Virology. 2023; 585:34-41.

PMID: 37271042 PMC: 10526635. DOI: 10.1016/j.virol.2023.05.002.


References
1.
Shah G, OShea C . Viral and Cellular Genomes Activate Distinct DNA Damage Responses. Cell. 2015; 162(5):987-1002. PMC: 4681434. DOI: 10.1016/j.cell.2015.07.058. View

2.
Stewart G, Wang B, Bignell C, Taylor A, Elledge S . MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 2003; 421(6926):961-6. DOI: 10.1038/nature01446. View

3.
Brown J . Herpes Simplex Virus Latency: The DNA Repair-Centered Pathway. Adv Virol. 2017; 2017:7028194. PMC: 5309397. DOI: 10.1155/2017/7028194. View

4.
Gibson W, Roizman B . Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc Natl Acad Sci U S A. 1971; 68(11):2818-21. PMC: 389533. DOI: 10.1073/pnas.68.11.2818. View

5.
Alekseev O, Donovan K, Azizkhan-Clifford J . Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis. Invest Ophthalmol Vis Sci. 2013; 55(2):706-15. PMC: 3912898. DOI: 10.1167/iovs.13-13461. View